Published in Exp Hematol on September 01, 2004
IFN-α in the treatment of melanoma. J Immunol (2012) 1.12
Inhibition of tumor cell motility by the interferon-inducible GTPase MxA. J Biol Chem (2009) 0.97
Directed evolution of gene-shuffled IFN-alpha molecules with activity profiles tailored for treatment of chronic viral diseases. Proc Natl Acad Sci U S A (2007) 0.80
Complete genome sequence and comparative analysis of the industrial microorganism Streptomyces avermitilis. Nat Biotechnol (2003) 7.84
Genome sequence of the streptomycin-producing microorganism Streptomyces griseus IFO 13350. J Bacteriol (2008) 4.59
An alternative menaquinone biosynthetic pathway operating in microorganisms. Science (2008) 2.46
The complete genomic sequence of Mycoplasma penetrans, an intracellular bacterial pathogen in humans. Nucleic Acids Res (2002) 2.17
Dysregulation of TGF-beta1 receptor activation leads to abnormal lung development and emphysema-like phenotype in core fucose-deficient mice. Proc Natl Acad Sci U S A (2005) 1.98
Adiponectin acts as an endogenous antithrombotic factor. Arterioscler Thromb Vasc Biol (2005) 1.88
Genome sequence of Symbiobacterium thermophilum, an uncultivable bacterium that depends on microbial commensalism. Nucleic Acids Res (2004) 1.82
Essential in vivo roles of the C-type lectin receptor CLEC-2: embryonic/neonatal lethality of CLEC-2-deficient mice by blood/lymphatic misconnections and impaired thrombus formation of CLEC-2-deficient platelets. J Biol Chem (2010) 1.77
FTY720, sphingosine 1-phosphate receptor modulator, ameliorates experimental autoimmune encephalomyelitis by inhibition of T cell infiltration. Cell Mol Immunol (2005) 1.74
The endothelial antigen ESAM marks primitive hematopoietic progenitors throughout life in mice. Blood (2008) 1.63
Reveromycin A biosynthesis uses RevG and RevJ for stereospecific spiroacetal formation. Nat Chem Biol (2011) 1.62
The Satb1 protein directs hematopoietic stem cell differentiation toward lymphoid lineages. Immunity (2013) 1.58
Cytochrome p450 complement (CYPome) of the avermectin-producer Streptomyces avermitilis and comparison to that of Streptomyces coelicolor A3(2). Biochem Biophys Res Commun (2003) 1.52
Complete deficiency in ADAMTS13 is prothrombotic, but it alone is not sufficient to cause thrombotic thrombocytopenic purpura. Blood (2005) 1.39
Genome sequence of Kitasatospora setae NBRC 14216T: an evolutionary snapshot of the family Streptomycetaceae. DNA Res (2010) 1.32
Isolation and expression profiling of genes upregulated in the peripheral blood cells of systemic lupus erythematosus patients. DNA Res (2006) 1.20
Paracrine regulation of fat cell formation in bone marrow cultures via adiponectin and prostaglandins. J Clin Invest (2002) 1.19
A pyrazole derivative potently inhibits lymphocyte Ca2+ influx and cytokine production by facilitating transient receptor potential melastatin 4 channel activity. Mol Pharmacol (2006) 1.13
Soluble frizzled-related protein 1 is estrogen inducible in bone marrow stromal cells and suppresses the earliest events in lymphopoiesis. J Immunol (2008) 1.11
Hydroxylation of testosterone by bacterial cytochromes P450 using the Escherichia coli expression system. Biosci Biotechnol Biochem (2006) 1.11
Adiponectin, a fat cell product, influences the earliest lymphocyte precursors in bone marrow cultures by activation of the cyclooxygenase-prostaglandin pathway in stromal cells. J Immunol (2003) 1.10
Integrin-linked kinase associated with integrin activation. Blood (2009) 1.06
Negative regulation of platelet function by a secreted cell repulsive protein, semaphorin 3A. Blood (2005) 1.05
Modulation of TLR4 signaling by a novel adaptor protein signal-transducing adaptor protein-2 in macrophages. J Immunol (2006) 1.05
Complement C1q regulates LPS-induced cytokine production in bone marrow-derived dendritic cells. Eur J Immunol (2004) 1.02
Tumour-associated macrophages in diffuse large B-cell lymphoma: a study of the Osaka Lymphoma Study Group. Histopathology (2012) 1.02
A novel therapeutic strategy with anti-CD9 antibody in gastric cancers. J Gastroenterol (2009) 1.01
The pituitary adenylate cyclase-activating polypeptide is a physiological inhibitor of platelet activation. J Clin Invest (2004) 0.99
YM-58483, a selective CRAC channel inhibitor, prevents antigen-induced airway eosinophilia and late phase asthmatic responses via Th2 cytokine inhibition in animal models. Eur J Pharmacol (2007) 0.99
Physical and functional interactions between Daxx and DNA methyltransferase 1-associated protein, DMAP1. J Immunol (2004) 0.98
Pathophysiology and management of primary immune thrombocytopenia. Int J Hematol (2013) 0.97
Trends of arbekacin-resistant MRSA strains in Japanese hospitals (1979 to 2000). J Antibiot (Tokyo) (2006) 0.97
Identification of nocobactin NA biosynthetic gene clusters in Nocardia farcinica. J Bacteriol (2010) 0.96
Fingolimod (FTY720), sphingosine 1-phosphate receptor modulator, shows superior efficacy as compared with interferon-β in mouse experimental autoimmune encephalomyelitis. Int Immunopharmacol (2010) 0.96
NAD-dependent histone deacetylase, SIRT1, plays essential roles in the maintenance of hematopoietic stem cells. Biochem Biophys Res Commun (2012) 0.95
The tetraspanin CD9 modulates epidermal growth factor receptor signaling in cancer cells. J Cell Physiol (2008) 0.95
CD9-mediated activation of the p46 Shc isoform leads to apoptosis in cancer cells. J Cell Sci (2004) 0.94
Cloning of the gene cluster responsible for the biosynthesis of brasilicardin A, a unique diterpenoid. J Antibiot (Tokyo) (2008) 0.94
Construction of a pair of practical Nocardia-Escherichia coli shuttle vectors. Jpn J Infect Dis (2007) 0.93
GATA transcription factors inhibit cytokine-dependent growth and survival of a hematopoietic cell line through the inhibition of STAT3 activity. J Biol Chem (2005) 0.92
Romiplostim for the treatment of chronic immune thrombocytopenia in adult Japanese patients: a double-blind, randomized Phase III clinical trial. Int J Hematol (2011) 0.92
NF-kappaB family proteins participate in multiple steps of hematopoiesis through elimination of reactive oxygen species. J Biol Chem (2004) 0.92
Epstein-Barr virus-derived EBNA2 regulates STAT3 activation. Biochem Biophys Res Commun (2008) 0.92
Involvement of tyrosine kinase-2 in both the IL-12/Th1 and IL-23/Th17 axes in vivo. J Immunol (2011) 0.91
The suppressive effects of YM-58483/BTP-2, a store-operated Ca2+ entry blocker, on inflammatory mediator release in vitro and airway responses in vivo. Pulm Pharmacol Ther (2007) 0.91
Regulation of human B lymphopoiesis by the transforming growth factor-beta superfamily in a newly established coculture system using human mesenchymal stem cells as a supportive microenvironment. Exp Hematol (2008) 0.91
Interaction between Src homology 2 domain bearing protein tyrosine phosphatase substrate-1 and CD47 mediates the adhesion of human B lymphocytes to nonactivated endothelial cells. J Immunol (2002) 0.91
Characterization of a bifunctional aminoglycoside-modifying enzyme with novel substrate specificity and its gene from a clinical isolate of methicillin-resistant Staphylococcus aureus with high arbekacin resistance. J Antibiot (Tokyo) (2004) 0.90
The density of CD10 corresponds to commitment and progression in the human B lymphoid lineage. PLoS One (2010) 0.90
A potential role for α-actinin in inside-out αIIbβ3 signaling. Blood (2010) 0.90
Helicobacter pylori activates gastric epithelial cells to produce interleukin-8 via protease-activated receptor 2. Digestion (2008) 0.89
Signal-transducing adaptor protein-2 regulates integrin-mediated T cell adhesion through protein degradation of focal adhesion kinase. J Immunol (2007) 0.88
Stromal cell-free conditions favorable for human B lymphopoiesis in culture. J Immunol Methods (2010) 0.88
Characterization of YM-58483/BTP2, a novel store-operated Ca2+ entry blocker, on T cell-mediated immune responses in vivo. Int Immunopharmacol (2008) 0.87
Monooxygenation of rifampicin catalyzed by the rox gene product of Nocardia farcinica: structure elucidation, gene identification and role in drug resistance. J Antibiot (Tokyo) (2009) 0.87
Successful treatment of duodenal myeloid sarcoma with allogeneic bone marrow transplantation and additional radiotherapy. Intern Med (2012) 0.87
STAP-2 negatively regulates both canonical and noncanonical NF-kappaB activation induced by Epstein-Barr virus-derived latent membrane protein 1. Mol Cell Biol (2008) 0.87
Combined autologous cellular cardiomyoplasty using skeletal myoblasts and bone marrow cells for human ischemic cardiomyopathy with left ventricular assist system implantation: report of a case. Surg Today (2009) 0.86
Interactions of STAP-2 with Brk and STAT3 participate in cell growth of human breast cancer cells. J Biol Chem (2010) 0.86
Transvalencin Z, a new antimicrobial compound with salicylic acid residue from Nocardia transvalensis IFM 10065. J Antibiot (Tokyo) (2006) 0.85
Identification of amino-terminal region of adiponectin as a physiologically functional domain. J Cell Biochem (2006) 0.85
Double-unit cord blood transplantation after myeloablative conditioning for patients with hematologic malignancies: a multicenter phase II study in Japan. Biol Blood Marrow Transplant (2013) 0.84
The endothelial antigen ESAM monitors hematopoietic stem cell status between quiescence and self-renewal. J Immunol (2012) 0.84
Krüppel-associated box-associated protein 1 negatively regulates TNF-α-induced NF-κB transcriptional activity by influencing the interactions among STAT3, p300, and NF-κB/p65. J Immunol (2011) 0.84
Agonist stimulation, talin-1, and kindlin-3 are crucial for α(IIb)β(3) activation in a human megakaryoblastic cell line, CMK. Exp Hematol (2012) 0.84
A Phase I/II study of nilotinib in Japanese patients with imatinib-resistant or -intolerant Ph+ CML or relapsed/refractory Ph+ ALL. Int J Hematol (2009) 0.84
Novel potent and selective calcium-release-activated calcium (CRAC) channel inhibitors. Part 2: Synthesis and inhibitory activity of aryl-3-trifluoromethylpyrazoles. Bioorg Med Chem (2006) 0.83
[A case of pseudothrombocytopenia due to platelet cold agglutinins]. Rinsho Byori (2005) 0.83
Antagonism of P2Y₁₂ reduces physiological thromboxane levels. Platelets (2010) 0.83
Transvalencin A, a thiazolidine zinc complex antibiotic produced by a clinical isolate of Nocardia transvalensis. I. Taxonomy, fermentation, isolation and biological activities. J Antibiot (Tokyo) (2004) 0.83
Cutting edge: tyk2 is required for the induction and nuclear translocation of Daxx which regulates IFN-alpha-induced suppression of B lymphocyte formation. J Immunol (2002) 0.83
Identification of functional domains and novel binding partners of STIM proteins. J Cell Biochem (2011) 0.83
Cultivable anaerobic microbiota of infected root canals. Int J Dent (2012) 0.83
Signal-transducing adaptor protein-2 regulates stromal cell-derived factor-1 alpha-induced chemotaxis in T cells. J Immunol (2009) 0.83
Sumoylation of Daxx regulates IFN-induced growth suppression of B lymphocytes and the hormone receptor-mediated transactivation. J Immunol (2006) 0.83
Association analysis of the NOD2 gene with susceptibility to graft-versus-host disease in a Japanese population. Int J Hematol (2011) 0.83
Antifungal activity of micafungin in serum. Antimicrob Agents Chemother (2009) 0.83
Tyk2 is a therapeutic target for psoriasis-like skin inflammation. Int Immunol (2013) 0.83
18F-FDG-PET in patients with malignant lymphoma having long-term follow-up: staging and restaging, and evaluation of treatment response and recurrence. Ann Nucl Med (2008) 0.82
A methyltransferase initiates terpene cyclization in teleocidin B biosynthesis. J Am Chem Soc (2014) 0.82
Reconstitution of biosynthetic machinery for the synthesis of the highly elaborated indole diterpene penitrem. Angew Chem Int Ed Engl (2015) 0.82
SHPS-1 negatively regulates integrin alphaIIbbeta3 function through CD47 without disturbing FAK phosphorylation. J Thromb Haemost (2005) 0.82
The exon-junction complex proteins, Y14 and MAGOH regulate STAT3 activation. Biochem Biophys Res Commun (2009) 0.82
Zipper-interacting protein kinase (ZIPK) modulates canonical Wnt/beta-catenin signaling through interaction with Nemo-like kinase and T-cell factor 4 (NLK/TCF4). J Biol Chem (2011) 0.82